Sitagliptin Tablet, Film Coated
Product Images NDC 0480-2609

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 0480-2609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

New (Image 1)

Chemical structure of sitagliptin, showing the arrangement of its fluorinated phenyl, amino, and triazolopyrazine groups with associated phosphate and water molecules.*

FDA Label Image

1 (Image 2)

A line graph showing the least squares mean change from baseline over a 24-week period for different treatments including placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, and combinations of Sitagliptin 50 mg twice daily with Metformin 500 mg or 1000 mg twice daily. The y-axis represents change values, and the x-axis represents time in weeks.*

FDA Label Image

2 (Image 3)

A line graph comparing the least squares mean change from baseline over 52 weeks between Sitagliptin 100 mg and Glipizide. The x-axis represents weeks, while the y-axis shows the change from baseline, with both drugs showing similar decreasing trends before stabilizing.*

FDA Label Image

25mg, 30ct (Image 4)

Sitagliptin Tablets USP 25 mg film-coated tablet label from Teva Pharmaceuticals, Inc. Contains 30 tablets indicated for oral use. The label includes medication guide instructions, storage conditions, manufacturer details (Watson Pharma Private Limited, India), and a barcode. The strength is prominently shown in a purple box.*

FDA Label Image

50mg, 30ct (Image 5)

Sitagliptin Tablets USP 50 mg film-coated tablets packaging label from Teva Pharmaceuticals, Inc. The label states 30 tablets per package with directions for pharmacists to dispense the accompanying medication guide. It includes storage instructions, manufacturer information listing Watson Pharma Private Limited in India, and a barcode with associated NDC 0480-2608-56.*

FDA Label Image

100mg, 30ct (Image 6)

Sitagliptin Tablets USP 100 mg film-coated tablet label by Teva Pharmaceuticals, Inc. The label indicates 30 tablets in the package and provides storage instructions and manufacturing details. It notes the active ingredient amount and dosage form, with a barcode and lot/expiration area on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.